Nova Realidade Covid-19 após 1 ano

Overview | Pharmaceutical Industry in Brazil 59% O Foreign Brazilian 41% Representativeness of the Brazilian industry in domestic sales in 2019 Competition in the Life Science segment has been intensifying in Brazil in recent years. Aiming to achieve greater economies of scale and the implementation of operational efficiency and the development of innovative products, the Brazilian pharmaceutical industry follows the path of organic growth, internationalization of its operations and acquisitions. Despite the national dominance in the sector, several foreign players enter the country attracted by the large domestic market and the opportunities to be explored in various market niches and regions. KPMG 66% 48% Volume Values Source: Revista da Farmácia, 2021 © 2021 KPMG Auditores Independentes, a Brazilian entity and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved. Printed in Brazil. BD210890 Page 107

View entire presentation